Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized study of tenapanor plus phosphate binders in hyperphosphatemia on hemodialysis
jRCT2080224556Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hyperphosphatemia and end-stage kidney disease (ESKD) comparing Tenapanor + phosphate binders with Placebo + phosphate binders (2 arms). Started Feb 2019; status: completed.
02
Drugs
tenapanor
03
Conditions
hyperphosphatemiaend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on jRCT2080224556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224556.